Corrigendum to ‘Pharmacodynamic analysis of intravenous bolus remimazolam for loss of consciousness in patients undergoing general anaesthesia: a randomised, prospective, double-blind study’ (Br J Anaesth 2022; 129: 49–57)

the fourth sentence in the Results section should read as follows:We propose optimal doses of 0.25e0.33,0.19e0.25,and 0.14e0.19mg kg À1 in patients aged <40, 40e60, and 60e80 yr, respectively, based on the ED95 estimates for the corresponding age groups.In the third paragraph of the Discussion, the second sentence should read as follows:Specifically, in patients aged <40, 40e60, and 60e80 yr, we propose optimal doses of 0.25e0.33,0.19e0.25,and 0.14e0.19mg kg À1 , respectively, based on the ED95 estimates in the corresponding age groups.